osudhkosh
New

৳ 14.75/unit

Pack: ৳ 413

TabletBox (28 Tablet)
Save to my medicines
Alert me on price drop

At a glance

Ethinylestradiol + Drospirenone + Levomefolate Calcium is a combined oral contraceptive pill used for contraception, PMDD symptoms, acne, and raising folate levels.

Indications
  • Contraception: Used as a combined oral contraceptive pill for prevention of pregnancy.
  • PMDD: Used for treatment of symptoms of premenstrual dysphoric disorder.
  • Acne: Used for treatment of moderate acne in women at least 14 years of age.
  • Folate Supplementation: Used to raise folate levels in women using oral contraception (to reduce risk of neural tube defects).
Pharmacology

Ethinylestradiol is a synthetic version of oestrogen and Drospirenone is a synthetic form of progesterone. The hormonal components inhibit ovulation by suppressing gonadotropin release. Drospirenone has antimineralocorticoid activity, counteracting oestrogen related sodium retention. Drospirenone exerts antiandrogenic activity. Levomefolate Calcium is a metabolite of vitamin B9.

Dosage

Adult Dose:

  • 1 tablet daily by mouth at the same time every day.
  • 24 active orange tablets, then 4 light orange non-hormonal tablets.
  • Start on the first day of menstruation (Day 1 Start) or first Sunday after onset (Sunday Start).
Side effects

Common Side Effects (>=2%):

  • Headache/migraine (5.9%)
  • Menstrual irregularities (4.1%)
  • Nausea/vomiting (3.5%)
  • Breast pain/tenderness (3.2%)
  • Fatigue (4.2%)
  • Irritability (2.8%)
  • Decreased libido (2.8%)
  • Weight gain (2.5%)

In PMDD trials: Menstrual irregularities (24.9%), nausea (15.8%), headache (13.0%), breast tenderness (10.5%).

Use in pregnancy

Use in Pregnancy: Do not use during pregnancy. If pregnancy occurs, discontinue.

Pregnancy Category: B3 — always consult a doctor before taking during pregnancy.

Precautions & warnings

Precautions:

  • Vascular risks: Stop if thrombotic event occurs; stop 4 weeks before major surgery and start 2 weeks after.
  • DRSP-containing COCs may be associated with higher risk of VTE.
  • Hyperkalemia: DRSP has antimineralocorticoid activity; do not use in patients predisposed to hyperkalemia.
  • Liver disease: Discontinue if jaundice occurs.
  • High blood pressure: Do not prescribe for women with uncontrolled hypertension.
  • Lactation: When possible, advise nursing mother to use other forms of contraception until weaned.
Overdose effects

Overdose: Overdose may cause nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness, fatigue; withdrawal bleeding may occur in females. No specific antidote; symptomatic treatment.

Storage conditions

Storage: Keep below 30 degree C, away from light and moisture. Keep out of reach of children.

Ethinylestradiol + Drospirenone + Levomefolate Calcium — see the full informationPharmacology, precautions, pregnancy, overdose and the rest on the generic page
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.